CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,154,003
- in 2 filings, $5.2M under 10b5-1 plans
Net −$5,154,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Goldberg Michael Director | Grant or award | +1,981 | 185,942 | ||
| 2026-04-01 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −7,386 | $17.87 | $132K | 169,392 |
| 2026-04-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −3,987 | $17.87 | $71K | 121,377 |
| 2026-04-01 | Hanna John Walter JR President and CEO | Shares withheld for taxes | −35,037 | $17.87 | $626K | 748,806 |
| 2026-04-01 | Kennedy Keith CFO & COO | Shares withheld for taxes | −11,725 | $17.87 | $210K | 197,414 |
| 2026-03-31 | Goldberg Michael Director | Option exercise | +5,255 | $5.02 | $26K | 162,716 |
| 2026-03-31 | Goldberg Michael Director | Option exercise | +9,745 | $4.95 | $48K | 172,461 |
| 2026-03-31 | Goldberg Michael Director | Option exercise | +11,500 | $1.22 | $14K | 183,961 |
| 2026-03-31 | Goldberg Michael Director | Option exercise · Stock Option (right to buy) | −5,255 | 0 | ||
| 2026-03-31 | Goldberg Michael Director | Option exercise · Stock Option (right to buy) | −9,745 | 0 | ||
| 2026-03-31 | Goldberg Michael Director | Option exercise · Stock Option | −11,500 | 0 | ||
| 2026-02-03 | Novack Jeffrey Adam Secretary and General Counsel | Sale | −4,441 | $20.56 | $91K | 125,364 |
| 2026-02-02 | SMITH NATHAN Chief Financial Officer | Grant or award | +33,000 | 75,000 | ||
| 2026-02-02 | SMITH NATHAN Chief Financial Officer | Grant or award | +7,875 | 82,875 | ||
| 2026-02-02 | SMITH NATHAN Chief Financial Officer | Shares withheld for taxes | −3,859 | $20.42 | $79K | 79,016 |
| 2026-02-02 | Meng Jessica Chief Commercial Officer | Grant or award | +60,000 | 169,629 | ||
| 2026-02-02 | Meng Jessica Chief Commercial Officer | Grant or award | +11,579 | 181,208 | ||
| 2026-02-02 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −4,430 | $20.42 | $90K | 176,778 |
| 2026-02-02 | Novack Jeffrey Adam Secretary and General Counsel | Grant or award | +33,000 | 130,925 | ||
| 2026-02-02 | Novack Jeffrey Adam Secretary and General Counsel | Grant or award | +4,342 | 135,267 |
Page 5 of 17 · 324 trades